PL360710A1 - Podstawione pochodne benzenu lub ich sole - Google Patents

Podstawione pochodne benzenu lub ich sole

Info

Publication number
PL360710A1
PL360710A1 PL01360710A PL36071001A PL360710A1 PL 360710 A1 PL360710 A1 PL 360710A1 PL 01360710 A PL01360710 A PL 01360710A PL 36071001 A PL36071001 A PL 36071001A PL 360710 A1 PL360710 A1 PL 360710A1
Authority
PL
Poland
Prior art keywords
salts
substituted benzene
benzene derivatives
carboxanilide
pyridyl
Prior art date
Application number
PL01360710A
Other languages
English (en)
Other versions
PL204898B1 (pl
Inventor
Tsukasa Ishihara
Fukushi Hirayama
Keizo Sugasawa
Yuji Koga
Takeshi Kadokura
Takeshi Shigenaga
Original Assignee
Yamanouchi Pharmaceutical Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co.Ltd. filed Critical Yamanouchi Pharmaceutical Co.Ltd.
Publication of PL360710A1 publication Critical patent/PL360710A1/pl
Publication of PL204898B1 publication Critical patent/PL204898B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Fats And Perfumes (AREA)
PL360710A 2000-11-22 2001-11-21 Podstawiona pochodna benzenu i zawierająca ja kompozycja farmaceutyczna oraz jej zastosowanie PL204898B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000356146 2000-11-22
JP2000390321 2000-12-22

Publications (2)

Publication Number Publication Date
PL360710A1 true PL360710A1 (pl) 2004-09-20
PL204898B1 PL204898B1 (pl) 2010-02-26

Family

ID=26604464

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360710A PL204898B1 (pl) 2000-11-22 2001-11-21 Podstawiona pochodna benzenu i zawierająca ja kompozycja farmaceutyczna oraz jej zastosowanie

Country Status (17)

Country Link
US (2) US7504417B2 (pl)
EP (1) EP1336605B1 (pl)
JP (1) JP3903920B2 (pl)
KR (1) KR100863923B1 (pl)
CN (1) CN1283626C (pl)
AT (1) ATE323071T1 (pl)
AU (2) AU2406402A (pl)
CA (1) CA2424522C (pl)
DE (1) DE60118774T2 (pl)
DK (1) DK1336605T3 (pl)
ES (1) ES2260336T3 (pl)
HU (1) HUP0400558A3 (pl)
MX (1) MXPA03003572A (pl)
PL (1) PL204898B1 (pl)
PT (1) PT1336605E (pl)
RU (1) RU2276137C2 (pl)
WO (1) WO2002042270A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
KR20040096541A (ko) * 2002-01-31 2004-11-16 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 인자 Xa 활성을 저해하는 화합물
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
KR20070007104A (ko) * 2004-02-18 2007-01-12 아스트라제네카 아베 화합물
BRPI0507746A (pt) * 2004-02-18 2007-07-10 Astrazeneca Ab composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
KR20070085371A (ko) * 2004-10-16 2007-08-27 아스트라제네카 아베 페녹시 벤즈아미드 화합물의 제조 방법
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
EP1847527A4 (en) 2005-02-02 2009-04-08 Ajinomoto Kk NEW BENZAMIDINE DERIVATIVE
EP1891069A1 (en) * 2005-05-24 2008-02-27 AstraZeneca AB 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
EP2027113A1 (en) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
KR101346902B1 (ko) * 2005-07-09 2014-01-02 아스트라제네카 아베 당뇨병 치료에 있어 glk 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
JP2009500442A (ja) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ 2型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての2−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200734304A (en) * 2005-11-08 2007-09-16 Astellas Pharma Inc Benzene derivative or salt thereof
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) * 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
KR20090090390A (ko) * 2006-12-21 2009-08-25 아스트라제네카 아베 Glk 활성제로서 유용한 신규 결정 화합물
JP2010120852A (ja) * 2007-03-09 2010-06-03 Daiichi Sankyo Co Ltd 新規なジアミド誘導体
WO2008135524A2 (en) * 2007-05-02 2008-11-13 Boehringer Ingelheim International Gmbh Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
EP2311810A4 (en) * 2008-07-11 2012-04-04 Ajinomoto Kk AMIDINE DERIVATIVE
EP2324028A2 (en) 2008-08-04 2011-05-25 AstraZeneca AB Therapeutic agents 414
TW201021832A (en) * 2008-09-30 2010-06-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2010116177A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04304012A (ja) * 1991-03-31 1992-10-27 Sony Corp フイルタ回路
US5417200A (en) * 1994-01-25 1995-05-23 Wasielewski; John J. Lantern cooker
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
ES2193202T3 (es) 1994-12-02 2003-11-01 Yamanouchi Pharma Co Ltd Nuevo derivado de amidinonaftilo o sal de este.
US6313151B1 (en) * 1997-06-26 2001-11-06 Eli Lilly And Company Antithrombotic agents
JP2002512633A (ja) * 1997-06-26 2002-04-23 イーライ・リリー・アンド・カンパニー 抗血栓剤
ES2241151T3 (es) * 1997-06-26 2005-10-16 Eli Lilly And Company Agentes antitromboticos.
EP1007037A4 (en) * 1997-06-26 2004-10-06 Lilly Co Eli ANTITHROMBOTIC AGENTS
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
ATE260103T1 (de) * 1997-12-19 2004-03-15 Schering Ag Ortho-anthranilamide derivate als antikoagulantien
WO1999037643A1 (en) 1998-01-26 1999-07-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzene-fused heterocyclic derivatives or salts thereof
CA2358095A1 (en) 1998-12-23 2000-07-06 Eli Lilly And Company Heteroroaromatic amides as inhibitor of factor xa
JP2004522689A (ja) * 1998-12-23 2004-07-29 イーライ・リリー・アンド・カンパニー 抗血栓アミド類
AU2055500A (en) * 1998-12-23 2000-07-31 Eli Lilly And Company Aromatic amides
JP4390024B2 (ja) 1999-04-23 2009-12-24 アステラス製薬株式会社 新規なジアゼパン誘導体又はその塩
CZ2002959A3 (cs) 1999-09-17 2002-07-17 Millennium Pharmaceuticals, Inc. Inhibitory faktoru Xa
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
ES2316383T3 (es) 1999-09-17 2009-04-16 Millennium Pharmaceuticals, Inc. Benzamidas e inhibidores relacionados del factor xa.
WO2001064642A2 (en) * 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
AU776053B2 (en) 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
DE60130771T2 (de) * 2000-07-27 2008-07-17 Eli Lilly And Co., Indianapolis Substituierte heterocyclische amide
US7163938B2 (en) * 2000-11-28 2007-01-16 Eli Lilly And Company Substituted carboxamides

Also Published As

Publication number Publication date
US7786106B2 (en) 2010-08-31
CN1283626C (zh) 2006-11-08
US20040077555A1 (en) 2004-04-22
US20090137498A1 (en) 2009-05-28
RU2276137C2 (ru) 2006-05-10
ATE323071T1 (de) 2006-04-15
PL204898B1 (pl) 2010-02-26
DE60118774D1 (de) 2006-05-24
EP1336605B1 (en) 2006-04-12
CN1476433A (zh) 2004-02-18
PT1336605E (pt) 2006-06-30
AU2002224064B2 (en) 2005-12-08
MXPA03003572A (es) 2003-07-14
US7504417B2 (en) 2009-03-17
CA2424522A1 (en) 2003-03-31
EP1336605A4 (en) 2004-01-28
ES2260336T3 (es) 2006-11-01
WO2002042270A1 (en) 2002-05-30
AU2406402A (en) 2002-06-03
KR100863923B1 (ko) 2008-10-17
CA2424522C (en) 2009-12-29
DE60118774T2 (de) 2007-03-15
DK1336605T3 (da) 2006-06-19
HUP0400558A2 (hu) 2004-06-28
JP3903920B2 (ja) 2007-04-11
EP1336605A1 (en) 2003-08-20
KR20030060944A (ko) 2003-07-16
JPWO2002042270A1 (ja) 2004-03-25
HUP0400558A3 (en) 2010-03-29

Similar Documents

Publication Publication Date Title
AU2406402A (en) Substituted benzene derivatives or salts thereof
DK0816376T3 (da) Thrombininhibitorer som antikoagulante midler
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ES2091068T3 (es) Combinaciones de productos activos fungicidas.
CO4910133A1 (es) Antagonistas de 5-h[1f]
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
DE69840645D1 (en) Benzamidinderivate
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
ATE407675T1 (de) Aspirin enthaltende medizinische zusammensetzungen
TW352329B (en) Fungicidal mixtures
GB8925833D0 (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
DK0682947T3 (da) Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
PT874843E (pt) 4-(1h-benzimidazol-2-il)¬1,4|diazepinos substituidos uteis para o tratamento de doencas alergicas
DE60045638D1 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
NO963469L (no) Substituert amidin-derivat og aggregasjonsblokkerer som inneholder dette
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
DE60126650D1 (de) Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen
MX9203362A (es) Composicion diuretica de benazepril/tiazida de dosis baja, para el tratamiento de la hipertension
ATE260102T1 (de) Benzamidin-derivate
NO924190L (no) Fremgangsmaate for fremstilling av homogene, fine, pulverformige faststoffdispersjoner som eventuelt inneholder virksomme substanser
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
SE9501773D0 (sv) New use
TH28200B (th) การใช้ (สูตร) il -อะโกนิสท์สำหรับรักษาการกลั้นปัสสาวะไม่อยู่

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20131121